Leiden, The Netherlands, 19 April 2024 – Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of.
Patients with SARS-CoV-2 infection experienced a 22% increase in the incidence of immune-mediated inflammatory diseases, including T1DM, IBD, and psoriasis.
The children in the study who developed SARS-CoV-2 antibodies had a risk of developing multiple islet autoantibodies that was a staggering 3.5 times higher than children who did not.
A recently published study found that since the start of the COVID-19 pandemic, the rate of new cases of type 1 diabetes in children has increased far beyond expectations.